- Company Overview for NUCLEOME THERAPEUTICS LIMITED (12109297)
- Filing history for NUCLEOME THERAPEUTICS LIMITED (12109297)
- People for NUCLEOME THERAPEUTICS LIMITED (12109297)
- More for NUCLEOME THERAPEUTICS LIMITED (12109297)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 Dec 2020 | TM01 | Termination of appointment of Lachlan Tom Mackinnon as a director on 16 October 2020 | |
30 Jul 2020 | CS01 | Confirmation statement made on 16 July 2020 with updates | |
19 Sep 2019 | AD01 | Registered office address changed from C/O Oxford Sciences Innovation 46 Woodstock Road Oxford OX2 6HT United Kingdom to Bioescalator Innovation Building University of Oxford Old Road Campus, Roosevelt Dr Oxford OX3 7FZ on 19 September 2019 | |
16 Aug 2019 | RESOLUTIONS |
Resolutions
|
|
09 Aug 2019 | PSC07 | Cessation of James Raymond Hughes as a person with significant control on 29 July 2019 | |
09 Aug 2019 | AP01 | Appointment of Danuta Mariola Jeziorska as a director on 2 August 2019 | |
07 Aug 2019 | PSC02 | Notification of Oxford Sciences Innovation Plc as a person with significant control on 2 August 2019 | |
07 Aug 2019 | SH01 |
Statement of capital following an allotment of shares on 2 August 2019
|
|
07 Aug 2019 | AP01 | Appointment of Mr Lachlan Tom Mackinnon as a director on 2 August 2019 | |
07 Aug 2019 | AD01 | Registered office address changed from Oxford Science Innovation King Charles House Park End Street Oxford Oxfordshire OX1 1JD United Kingdom to C/O Oxford Sciences Innovation 46 Woodstock Road Oxford OX2 6HT on 7 August 2019 | |
31 Jul 2019 | SH01 |
Statement of capital following an allotment of shares on 29 July 2019
|
|
17 Jul 2019 | NEWINC |
Incorporation
Statement of capital on 2019-07-17
|